Scleroderma, Localized
-
Subject Areas on Research
- A novel patient-reported outcome for paediatric localized scleroderma: a qualitative assessment of content validity.
- A systematic review of morphea treatments and therapeutic algorithm.
- Acute kidney injury in patients with systemic sclerosis participating in hematopoietic cell transplantation trials in the United States.
- Atypical Localized Scleroderma Development During Nivolumab Therapy for Metastatic Lung Adenocarcinoma.
- Brief Report: HLA-DRB1, DQA1, and DQB1 in Juvenile-Onset Systemic Sclerosis.
- Clinical and Molecular Findings After Autologous Stem Cell Transplantation or Cyclophosphamide for Scleroderma: Handling Missing Longitudinal Data.
- Developing comparative effectiveness studies for a rare, understudied pediatric disease: lessons learned from the CARRA juvenile localized scleroderma consensus treatment plan pilot study.
- Development of consensus treatment plans for juvenile localized scleroderma: a roadmap toward comparative effectiveness studies in juvenile localized scleroderma.
- Durometry as an outcome measure in juvenile localized scleroderma.
- Evaluation of the Effectiveness and Tolerability of Mycophenolate Mofetil and Mycophenolic Acid for the Treatment of Morphea.
- Exploring the impact of paediatric localized scleroderma on health-related quality of life: focus groups with youth and caregivers.
- Extracutaneous involvement is common and associated with prolonged disease activity and greater impact in juvenile localized scleroderma.
- Fibrinolytic abnormalities in two different cutaneous manifestations of venous disease.
- Health-related quality of life in children and adolescents with juvenile localized scleroderma.
- Immunophenotyping of chimeric cells in localized scleroderma.
- Initial Results from a Pilot Comparative Effectiveness Study of 3 Methotrexate-based Consensus Treatment Plans for Juvenile Localized Scleroderma.
- Interferon-gamma inducible protein-10 as a potential biomarker in localized scleroderma.
- Localized morphea: a rare adverse effect of valproic acid.
- Morphea following treatment with pembrolizumab for melanoma with metastatic lymph nodes: case report and review of literature.
- New Features for Measuring Disease Activity in Pediatric Localized Scleroderma.
- Parry-Romberg syndrome with fatal brain stem involvement.
- Periarterial sympathectomy in scleroderma patients: intermediate-term follow-up.
- Peripheral blood cytokine and chemokine profiles in juvenile localized scleroderma: T-helper cell-associated cytokine profiles.
- Post-irradiation morphoea of the breast: a case report and review of the literature.
- Prediction of disease relapse in a cohort of paediatric patients with localized scleroderma.
- Predictors of Longitudinal Quality of Life in Juvenile Localized Scleroderma.
- Preliminary evidence on abatacept safety and efficacy in refractory juvenile localized scleroderma.
- Quantifying Skin Stiffness in Graft-Versus-Host Disease, Morphea, and Systemic Sclerosis Using Acoustic Radiation Force Impulse Imaging and Shear Wave Elastography.
- Review: Hematopoietic Stem Cell Transplantation for Scleroderma: Effective Immunomodulatory Therapy for Patients With Pulmonary Involvement.
- The Localized Scleroderma Cutaneous Assessment Tool: responsiveness to change in a pediatric clinical population.
- The importance of development standards for anchoring vignettes: an illustrative example from pediatric localized scleroderma quality of life.
- The localized scleroderma skin severity index and physician global assessment of disease activity: a work in progress toward development of localized scleroderma outcome measures.
- Transcutaneous PO2 monitoring for assessing viability and predicting survival of skin flaps: experimental and clinical correlations.
-
Keywords of People
- Ardalan, Kaveh, Assistant Professor of Pediatrics, Pediatrics, Rheumatology